Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0961-2025

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064 Recall

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064

FDA recall Class II

Ongoing

FDA lists this Class II recall for VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0961-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Dec 2, 2024
FDA report date
Jan 22, 2025
Quantity in commerce
25
Distribution
See key details
FDA cause
Process control

What is being recalled?

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064

Affected model & UDI checker

Search the exact identifiers published for Z-0961-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
85064VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064Check source noticeNot specified
Not specifiedVerifyNow P2Y12 Platelet Reactivity Test, REF: 85064Check source notice10711234150054
FDA code information

UDI-DI: 10711234150054. Lot: WL1145. Expiration: 2025-10-18

View the original FDA recall notice

Why was this product recalled?

Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.

What actions did Accriva Diagnostics, Inc. take?

On 12/02/2024, a recall notice was mailed to the customer who was asked to do the following: 1.Forward this communication to those within your organization who need to become aware of this matter and verify they understand the procedure and can complete the enclosed forms. 2. In addition, forward the enclosed customer notification to all other organizations where affected devices may have been transferred to. 3. Destroy all impacted boxes. 4. Complete and return the tracking form via email to [email protected] If you have questions regarding replacement product, please contact the firm's Customer Service at 800-955-9525 or e-mail [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology